Home › Funds › ARMISTICE CAPITAL, LLC › ANGO
ARMISTICE CAPITAL, LLC position in ANGO
ANGIODYNAMICS INC · Health Care
ARMISTICE CAPITAL, LLC reported holding 2,198,000 shares of ANGO (ANGIODYNAMICS INC) in its Q2 2026 13F filing — a position valued at US$28.6M, representing 0.38% of its reported portfolio and ranking #37 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed ANGO holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ARMISTICE CAPITAL, LLC's ANGO position evolved
ARMISTICE CAPITAL, LLC first disclosed a stake in ANGO in Q4 2023 at 800,000 shares (US$6.3M). The position peaked in Q2 2026 at 2,198,000 shares, worth US$28.6M. Across 11 filings, ARMISTICE CAPITAL, LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,198,000 shares valued at US$28.6M — an increase of 329,000 shares quarter over quarter.. Notable position changes include a 140% increase in Q1 2025 (shares rose 6% over the following quarter), a 27% trim in Q2 2025 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 800.00K | $6.27M | New |
| Q1 2024 | 872.00K | $5.12M | Add |
| Q2 2024 | 836.00K | $5.06M | Reduce |
| Q3 2024 | 962.00K | $7.48M | Add |
| Q4 2024 | 872.00K | $7.99M | Reduce |
| Q1 2025 | 2.09M | $19.66M | Add |
| Q2 2025 | 1.53M | $15.16M | Reduce |
| Q3 2025 | 1.64M | $18.27M | Add |
| Q4 2025 | 1.70M | $21.83M | Add |
| Q1 2026 | 1.87M | $21.25M | Add |
| Q2 2026 | 2.20M | $28.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANGO and 13F data
ANGO (ANGIODYNAMICS INC) is a Health Care company. 26 other funds we track also report a position in ANGO — the largest reported positions include SYSTEMATIC FINANCIAL MANAGEMENT LP (US$34.3M), Broadfin Holdings LLC (US$23.7M), WEBER CAPITAL MANAGEMENT LLC /ADV (US$20.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANGO
- SYSTEMATIC FINANCIAL MANAGEMENT LP 2.64M sh · $34.35M · Q2 2026
- Broadfin Holdings LLC 1.82M sh · $23.66M · Q2 2026
- WEBER CAPITAL MANAGEMENT LLC /ADV 1.35M sh · $20.76M · Q3 2026
- Bastion Asset Management Inc. 923.27K sh · $10.78M · Q2 2026
- Pier Capital, LLC 806.68K sh · $10.49M · Q2 2026
More on ARMISTICE CAPITAL, LLC
FAQ
How long has ARMISTICE CAPITAL, LLC held ANGO?
ARMISTICE CAPITAL, LLC has disclosed ANGO holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is ARMISTICE CAPITAL, LLC's current position in ANGO?
As of Q2 2026, ARMISTICE CAPITAL, LLC holds 2.20M shares of ANGO (ANGIODYNAMICS INC), valued at $28.60M, representing 0.38% of its reported portfolio and ranking #37.
Has ARMISTICE CAPITAL, LLC been buying or selling ANGO?
In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC increased its position in ANGO. The position peaked in Q2 2026 at 2.20M shares.
Which other funds hold ANGO?
Other major institutional holders of ANGO include SYSTEMATIC FINANCIAL MANAGEMENT LP, Broadfin Holdings LLC, WEBER CAPITAL MANAGEMENT LLC /ADV, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.